Circulating blood B cells in multiple myeloma: Analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the eastern cooperative oncology group phase III E9486 clinical trial

Blood

Volumn 90, Issue 1, 1997, Pages 340-345

  Kay, Neil E ^a   Leong, Traci ^b   Kyle, Robert A ^b   Greipp, Philip ^b   Billadeau, Daniel ^b   Van Ness, Brian ^b   Bone, Nancy ^b   Oken, Martin M ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CD19 ANTIGEN; INTERLEUKIN 6 RECEPTOR;

ARTICLE; B LYMPHOCYTE; CELL CLONE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PRIORITY JOURNAL;

EID: 0030991936     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.1.340     Document Type: Article

References (23)

1. Kubagawa H, Vogler LB, Capra JD, Conrad ME, Lawton AR, Cooper MD: Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation. J Exp Med 150:792, 1979
2. Bast EJ, Van Camp B, Reynaert P, Wiringa G, Ballieux RE: Idiotypic peripheral blood lymphocytes in monoclonal gammopathy. Clin Exp Immunol 47:677, 1982
3. Pettersson D, Mellstedt H, Holm G, Bjorkholm M: Monoclonal blood lymphocytes in benign monoclonal gammopathy and multiple myeloma in relation to clinical stage. J Haematol 27:287, 1981
4. vanReit I, Heirman C, Lacor P, DeWaele M, Thielemas K, vanCamp B: Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies. Br J Haematol 73:289, 1989
5. Levy Y, Schmitt C, Tsapis A, Brouet JC, Fermand JP: Phenotype and immunoglobulin gene configuration of blood B cells from patients with multiple myeloma. Clin Exp Immunol 84:435, 1991
6. Pilarski LM, Jensen GS: Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules. Hematol Oncol Clin North Am 6:297, 1992
7. Harada Y, Kawano MM, Huan N, Mahmoud MS, Lisukov IA, Mihara K, Tsujimoto T, Kuramoto A: Identification of early plasma cells in peripheral blood and their clinical significance. Br J Haematol 92:184, 1996
8. Tedder TF, Isaacs CM: Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily. J Immunol 143:712, 1989
9. Fearon DT, Carter RH: The CD19/CR2/TAPA-1 complex of B lymphocytes: Linking natural to acquired immunity. Annu Rev Immunol 13:127, 1995
10. Kipps TJ, Meisenholder G, Robbins BA: New developments in flow cytometric analysis of lymphocyte markers. Clin Lab Immunol 12:237, 1992
11. Billadeau D, Quam L, Thomas W, Kay N, Kyle R, Greipp PR, Oken M, Van Ness B: Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 80:1818, 1992
12. Billadeau B, Blackstadt M, Greipp PR, Kyle RA, Oken MM, Kay NE, Van Ness B: Analysis of B-lymphoid malignancies using allele specific polymerase chain reaction: A technique for sequential quantification of residual disease. Blood 78:3021, 1991
13. Greipp PR, Witzig TE, Gonchoroff NJ, Habermann TM, Katzmann JA, O'Fallon WM, Kyle RA: Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies. Mayo Clin Proc 62:969, 1987
14. Gaillard JP, Bataille R, Brailly H, Zuber C, Yasukawa K, Attal M, Maruo N, Taga T, Kishimoto T, Klein B: Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. Eur J Immunol 23:820, 1993
15. LeBlanc M, Crowley J: Relative risk trees for censored survival data. Biometrics 48:411, 1992
16. Oken MM, Creech RH, Tormey CD, Horton J, Davis TE, McFadden, E, Carbone P: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649, 1982
17. Cassel A, Leibovitz N, Hornstein L, Quitt M, Aghai E: Evidence for the existence of circulating monoclonal B-lymphocytes in multiple myeloma patients. Exp Hematol 18: 1171, 1990
18. Mellstedt H, Hammarstrom S, Holm G: Monoclonal lymphocytes populations in human plasma cell myeloma. Clin Exp Immunol 17:371, 1974
19. Berenson JR, Lichtenstein AK: Clonal rearrangement of immunoglobulin genes in the peripheral blood of multiple myeloma patients. Br J Haematol 73:425, 1989
20. Bergsagel PL, Smith AM, Sczepek A, Maut MJ, Belch AR, Pilarski LM: In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56 and monotypic Ig light chain. Blood 85:436, 1995
21. Billadeau D, Van Ness B, Kimlinger T, Kyle R, Therneau TM, Greipp PR, Witzig T: Clonal circulating cells are common occurrence in plasma cell disorders: A comparison of MGUS, SMM and MM. Blood 88:289, 1996
22. Chen BJ, Epstein J: Circulating clonal lymphocytes in multiple myeloma constitute a minor subpopulation of B cells. Blood 87:1972, 1996
23. Tsujimoto T, Lisukov IA, Huan N, Mahmoud MS, Kawano MM: Plasma cells induce apoptosis of pre-B cells by interacting with bone marrow stromal cells. Blood 87:3375, 1996